PX5-9 is an orally active prodrug that can upregulate brain-derived neurotrophic factor (BDNF). PX5-9 exerts neuroprotective effects by elevating intracellular BDNF levels. PX5-9 can be used for the research of neurodegenerative diseases (such as Alzheimers disease, Parkinsons disease) and depression, which are associated with reduced BDNF levels[1].
Molekulargewicht:
396.48
Formel:
C23H28N2O4
Target-Kategorie:
Drug Metabolite
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
